Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

PayPal Holdings, Inc. (PYPL) Is a Trending Stock: Facts to Know Before Betting on It
PayPal Holdings, Inc. (PYPL) Is a Trending Stock: Facts to Know Before Betting on It

Paypal (PYPL) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the

Is Trending Stock Palo Alto Networks, Inc. (PANW) a Buy Now?
Is Trending Stock Palo Alto Networks, Inc. (PANW) a Buy Now?

Palo Alto Networks (PANW) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's

Should You Be Greedy When Others are Fearful? ETFs in Focus
Should You Be Greedy When Others are Fearful? ETFs in Focus

There is a famous saying by legendary investor Warren Buffett – “Be fearful when others are greedy and greedy when others are fearful.”

Now that most investors have gone into panic mode due to the

Buy 3 Stocks With Upgraded Broker Ratings as Geopolitical Woes Linger: https://staticx-tuner.zacks.com/images/articles/main/25/147769.webp
Buy 3 Stocks With Upgraded Broker Ratings as Geopolitical Woes Linger

This year started on a subdued note. U.S. markets have seen bouts of selling tied to shifting AI expectations and geopolitical tensions, especially Middle East risks and oil-shock fears, prompting

Is the Options Market Predicting a Spike in Akebia Therapeutics Stock?
Is the Options Market Predicting a Spike in Akebia Therapeutics Stock?

Investors in Akebia Therapeutics, Inc. AKBA need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2026 $0.50 Call had some of the highest

How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now
Why Investors Need to Take Advantage of These 2 Consumer Discretionary Stocks Now

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Fast-paced Momentum Stock Jabil (JBL) Is Still Trading at a Bargain
Fast-paced Momentum Stock Jabil (JBL) Is Still Trading at a Bargain

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

Ciena Surges 73% in 3 Months: Should Investors Still Buy the Stock?
Ciena Surges 73% in 3 Months: Should Investors Still Buy the Stock?

Ciena Corporation CIEN stock has surged 72.7% in the past three months, outperforming the Zacks Communication - Components industry’s growth of 53.3%. The S&P 500 composite and Zacks Computer &

Nissan Teams Up With Wayve and Uber to Develop Robotaxis: https://staticx-tuner.zacks.com/images/articles/main/da/471.jpg
Nissan Teams Up With Wayve and Uber to Develop Robotaxis

Nissan Motor Co., Ltd. NSANY, Wayve and Uber Technologies, Inc. UBER have signed a memorandum of understanding to jointly develop robotaxis and begin efforts toward launching autonomous ride

Will Anktiva Continue to Drive ImmunityBio's Top-Line Growth in 2026?
Will Anktiva Continue to Drive ImmunityBio's Top-Line Growth in 2026?

ImmunityBio IBRX had an encouraging year in 2025. Last month, the company reported its fourth-quarter and full-year 2025 results, which beat both our earnings and sales estimates — all thanks to the

What's Behind Ford's Approval of a New Share Repurchase Plan?
What's Behind Ford's Approval of a New Share Repurchase Plan?

Ford Motor Company F has approved a plan to repurchase up to 31.7 million shares of its stock, a relatively modest buyback to counteract dilution from employee compensation and other convertible

Software Stocks Are Down—Expert Says These 3 Names Still Look Strong
Software Stocks Are Down—Expert Says These 3 Names Still Look Strong

Software stocks have been under pressure, but not every company in the sector deserves to be sold off with the group. In a recent conversation with Kuran Francis of FinTek, the discussion focused

Lucid's Investor Day Signals Big Ambitions: Buy LCID Stock Now?: https://staticx-tuner.zacks.com/images/articles/main/57/141355.webp
Lucid's Investor Day Signals Big Ambitions: Buy LCID Stock Now?

At its investor day last week, Lucid Group LCID outlined how it plans to evolve from a niche luxury EV maker to a scaled, technology-driven mobility platform. The company detailed its upcoming

X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates
X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $6.01 per share a year ago. These

Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates
Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates

Monte Rosa Therapeutics (GLUE) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to earnings of $0.23 per share a year ago

CVNA Stock Before 5-for-1 Split: Do Fundamentals Justify a Buy Now?
CVNA Stock Before 5-for-1 Split: Do Fundamentals Justify a Buy Now?

Used vehicle e-retailer Carvana CVNA recently approved a 5-for-1 forward stock split, its first-ever stock split. Effective May 7, the shares will begin trading on a split-adjusted basis.

Stock

2 Stocks With Governmental Tailwinds to Drive Them Higher
2 Stocks With Governmental Tailwinds to Drive Them Higher

A little government exposure can go a long way for a business, especially those still in their early phases. Government spending, specifically defense, accounts for approximately 3% of GDP, making

GDS Holdings (GDS) Beats Q4 Earnings and Revenue Estimates
GDS Holdings (GDS) Beats Q4 Earnings and Revenue Estimates

GDS Holdings (GDS) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.1 per share a year ago. These

Kinross Gold Delivers Record Q4 Margins: Can it Sustain the Momentum?
Kinross Gold Delivers Record Q4 Margins: Can it Sustain the Momentum?

Kinross Gold Corporation KGC logged a record fourth-quarter operating margin, courtesy of a rally in gold prices, cost management and strong production performance. Its margin per gold equivalent

FEAM Strengthens Position With High-Margin Boron Innovation
FEAM Strengthens Position With High-Margin Boron Innovation

5E Advanced Materials, Inc. FEAM recently reported a key R&D milestone with the production of a proprietary meta boric acid product featuring 80% B2O3 content, higher than conventional boric acid

Quaker Chemical and EV Fluids: Why APAC Wins Matter in 2026
Quaker Chemical and EV Fluids: Why APAC Wins Matter in 2026

Quaker Chemical Corporation KWR is showing pockets of growth, even as many end markets stay muted. The company’s outgrowth is being shaped by sustained share gains and electric vehicle (EV)-related

KWR Stock: Undervalued Play or Execution Risk Waiting to Unfold?
KWR Stock: Undervalued Play or Execution Risk Waiting to Unfold?

Quaker Chemical Corporation KWR is in a tug-of-war between improving fundamentals and a stock that has lagged meaningfully. Investors are weighing a discounted valuation against near-term friction

Can Execution Power Quaker Chemical's Growth in a Soft Market?
Can Execution Power Quaker Chemical's Growth in a Soft Market?

Quaker Chemical Corporation KWR is heading into 2026 with muted end-market expectations, but management still sees a path to steady growth. The investment debate centers on whether the company can

3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio
3 Top-Performing Mutual Funds to Consider for Your Retirement Portfolio

There is never a wrong time to invest in mutual funds for retirement. So, if you're still looking for the best mutual funds, the Zacks Mutual Fund Rank can be a great guide.

The best way to